Introduction Generic Name: Osimertinib Common Brand Names: Tagrisso, Ositab, Osimert Strength: 80 mg tablet Drug Class: Third-generation EGFR tyrosine kinase inhibitor (EGFR-TKI) Indication: Non-small cell lung cancer (NSCLC) with EGFR mutation Osimertinib is an oral anticancer medication used in the targeted treatment of certain types of advanced lung cancer, specifically non-small cell lung cancer (NSCLC) with EGFR gene mutations, including T790M resistance mutation. What Is Osimertinib Used For? Osimertinib is approved […]
